Last reviewed · How we verify
Epinephrine 1:100,000
At a glance
| Generic name | Epinephrine 1:100,000 |
|---|---|
| Sponsor | Rio de Janeiro State University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of Postoperative Effects of Articaine and Lidocaine in Mucogingival Surgery (NA)
- Articaine Infiltration in Anesthetizing Mandibular Second Primary Molars (NA)
- Bupivacaine Versus Lidocaine Infiltration for Postoperative Pain in Thyroid Surgery (PHASE2)
- Articaine Efficiency in Pulpectomy of Children With Irreversible Pulpitis Under the Age of Four (NA)
- Different Autologous Products in The Treatment of Intrabony Defects (NA)
- Ultrasound-guided Genicular Nerve Block for Total Knee Arthroplasty. (PHASE4)
- Adrenaline Solution Irrigation and Bleeding During Sinus Surgery (PHASE1)
- Evaluation of Intraoperative Lagophthalmos Formula (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Epinephrine 1:100,000 CI brief — competitive landscape report
- Epinephrine 1:100,000 updates RSS · CI watch RSS
- Rio de Janeiro State University portfolio CI